GUAYAQUIL, Ecuador, 14 de junio de 2026 /PRNewswire/ — La Secretaría de Turismo de Ecuador ha lanzado Ecuador 2026, una campaña turística internacional que utiliza el fútbol como plataforma para promocionar el país ante audiencias de todo el mundo durante uno de los momentos más visibles…
GUAYAQUIL, Ecuador, 14. Juni 2026 /PRNewswire/ — Die ecuadorianische Tourismusbehörde hat „Ecuador 2026″ gestartet, eine internationale Tourismuskampagne, die den Fußball als Plattform nutzt, um das Land in einer Phase, in der dieser Sport weltweit besonders stark im Blickpunkt steht,…
GUAYAQUIL, Équateur, 14 juin 2026 /PRNewswire/ — Le secrétaire au Tourisme de l’Équateur a lancé Ecuador 2026, une campagne touristique internationale qui utilise le football comme tremplin pour promouvoir le pays auprès d’un public international lors de l’un des événements les plus…
In the heart of the Central African Republic (CAR), a nation long marked by conflict, Nina Mireille Yankinon stands as a symbol of resilience, leadership, and hope, dedicating her life to helping communities torn apart by war.
FDA, CDC, and public health officials in California, Pennsylvania, and Washington are investigating; food safety attorney Bill Marler calls it the second formula-linked infant botulism outbreak in seven months and renews his demand that the FDA and the infant formula industry do more….
SHANGHAI, 13. Juni 2026 /PRNewswire/ — Am 29. Mai 2026 (Pacific Time) schloss die Simcere Pharmaceutical Group Limited (2096.HK) eine Forschungskooperationsvereinbarung mit Stanford Medicine ab, um gemeinsam eine explorative Studie im Bereich der Atemwegserkrankungen voranzutreiben, mit…
NEW YORK and ATHENS, Greece, June 13, 2026 /PRNewswire/ — Kos Biotechnology Partners (“Kos”), a global life sciences investment firm bridging the US biopharma ecosystem with Europe, today announced the third closing of its inaugural global life sciences fund, bringing total capital…
GOTHENBURG, Sweden, June 13, 2026 /PRNewswire/ — MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies that drive innovation in life sciences, is showcasing its latest advancements in sequencing, automation and clinical genomics at the European Society…
INDIANAPOLIS, June 13, 2026 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced new data from the Phase 1 AJX-101 study showing that its investigational type II JAK2 inhibitor (AJ1-11095) demonstrated an encouraging safety profile and promising clinical activity in patients…
